3-ALPHA-ACETOXY-5-ALPHA-CHOLESTAN-5-ALPHA-OL
Compound with spectra: 1 NMR, and 1 MS (GC)
| SpectraBase Compound ID | 2aRAo3wh8PG |
|---|---|
| InChI | InChI=1S/C29H50O3/c1-19(2)8-7-9-20(3)24-10-11-25-23-13-17-29(31)18-22(32-21(4)30)12-16-28(29,6)26(23)14-15-27(24,25)5/h19-20,22-26,31H,7-18H2,1-6H3/t20-,22-,23+,24-,25+,26+,27-,28-,29-/m1/s1 |
| InChIKey | XGBHFLNWQIPOQW-DAECALLPSA-N |
| Mol Weight | 446.7 g/mol |
| Molecular Formula | C29H50O3 |
| Exact Mass | 446.375995 g/mol |
| Enantiomer InChIKey | XGBHFLNWQIPOQW-VXJOJCLVSA-N |
| Copyright | Copyright © 2011-2024 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Prof. Spiteller, University Bayreuth, Germany |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- 5-Hydroxycholestan-3-yl acetate
- 3.ALPHA.-ACETOXY-5.ALPHA.-CHOLESTAN-5-OL
- (3R,5R,8S,9S,10R,13R,14S,17R)-5-hydroxy-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
Ethyl 3.beta.-acetoxy-5.alpha.-hydroxy-24-nor-cholan-23-oate
(24S)-24-ETHYL-5-ALPHA-CHOLESTANE-3-BETA,5-DIOL
Methyl 5.beta.-hydroxy-3-oxocholan-24-oate
5-ALPHA-CHOLESTANE-4-BETA,5-DIOL
5-BETA-CHOLESTANE-4-BETA,5-DIOL
Androstan-17-one, 3-(acetyloxy)-5-hydroxy-, (3.beta.,5.alpha.)-
Cholestan-4-one, 5-hydroxy-, (5.alpha.)-
Androstane-17-carboxylic acid, 3,5-dihydroxy-, methyl ester, (3.beta.,5.alpha.,17.beta.)-
5,19-Cyclo-5.beta.-cholestan-3.beta.-ol, acetate
Cholestan-3-one, 5-(trimethylsilyl)-
| Title | Journal or Book | Year |
|---|---|---|
| Additivity relations in carbon-13 nuclear magnetic resonance spectra of dihydroxy steroids | The Journal of Organic Chemistry | 1977 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.